Key policy issues
Monitoring and evaluation are an essential part of a national drug policy, and the necessary provisions need to be included in the policy. Key policy issues are:
• explicit government commitment to the principles of monitoring and evaluation;
• monitoring of the pharmaceutical sector through regular indicator-based surveys;
• independent external evaluation of the impact of the national drug policy on all sectors of the community and the economy.